文献速递重症综合管理与镇静镇痛

ICU多研究运营:一种跨专业、疫情启示的方法

Multistudy Research Operations in the ICU: An Interprofessional Pandemic-Informed Approach.
PubMed 文献 · Crit Care Explor · 2022-12-01
一句话结论学术ICU通过跨专业研究运营委员会协调多项研究,COVID-19试验知情同意率77.5%低于其他试验89.7%,COVID-19患者更常被共同入组。

该研究描述加拿大学术ICU在COVID-19疫情期间两个研究运营委员会的起源、目标、参与、流程和结局。2020年3月至2021年5月,5项非COVID试验继续、2项暂停后重启、5项启动;15个月内161例患者参与215次入组,总体知情同意率83%(215/259),COVID-19试验77.5%(110/142)低于其他试验89.7%(105/117,p=0.01);COVID-19患者共同入组≥2项研究比例37.7%(29/77)高于其他患者15.5%(13/84,p=0.002)。结构化协调和沟通提升了临床研究运营的完整性。

要点

  • 2020年3月至2021年5月,学术ICU内5项非COVID试验继续、2项暂停后重启、5项启动,共161例患者参与215次入组。
  • 总体知情同意率83%(215/259);COVID-19试验77.5%(110/142)低于其他试验89.7%(105/117),p=0.01。
  • COVID-19患者共同入组≥2项研究比例37.7%(29/77)高于其他患者15.5%(13/84),p=0.002。
  • 跨专业COVID协作组在疫情初期成立,协调研究、协助知情同意并确定适合共同入组的研究。
  • 2021年6月扩展为重症医学科研究运营委员会,以支持疫情期间及之后可持续的研究运营。

适用人群与场景

  • 加拿大安大略省汉密尔顿市大学附属ICU的成人患者,所在病房包括ICU、医疗降阶梯病房或COVID-19病房。

处置流程与药物剂量

  • 疫情初期在本科室成立跨专业COVID协作组,主动协调研究、协助不同研究人员的多次知情同意沟通,并确定哪些研究适合共同入组。

研究设计与关键结果

  • 研究设计为两阶段、单中心多研究队列;2020年3月至2021年5月,5项非COVID试验继续,2项暂停后重启,5项启动。
  • 15个月内161例患者参与215次试验入组,其中110次(51.1%)入组COVID治疗试验。
  • 总体知情同意率(同意人数占符合条件且被接触者比例,包括事先知情同意和延迟知情同意模式)为83%(215/259)。
  • COVID-19试验知情同意率为77.5%(110/142),低于其他试验的89.7%(105/117),p=0.01。
  • COVID-19患者共同入组两项或以上研究的比例为37.7%(29/77),高于其他患者的15.5%(13/84),p=0.002。
  • 每项新研究的审查条目经过整理、细化并发展为可修改的清单模板,以助力每项研究成功启动。
  • COVID协作组于2021年6月扩展为更正式的重症医学科研究运营委员会,支持疫情期间及之后可持续的研究运营。

证据类型、等级与局限

  • 证据类型:两阶段、单中心多研究队列。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,跨不同研究利益相关方的结构化协调和关于研究运营的更多沟通,培育了共同目标感并提升了临床研究运营的完整性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Proliferation of COVID-19 research underscored the need for improved awareness among investigators, research staff and bedside clinicians of the operational details of clinical studies. The objective was to describe the genesis, goals, participation, procedures, and outcomes of two research operations committees in an academic ICU during the COVID-19 pandemic.

DESIGN: Two-phase, single-center multistudy cohort.

SETTING: University-affiliated ICU in Hamilton, ON, Canada.

PATIENTS: Adult patients in the ICU, medical stepdown unit, or COVID-19 ward.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: An interprofessional COVID Collaborative was convened at the pandemic onset within our department, to proactively coordinate studies, help navigate multiple authentic consent encounters by different research staff, and determine which studies would be suitable for coenrollment. From March 2020 to May 2021, five non-COVID trials continued, two were paused then restarted, and five were launched. Over 15 months, 161 patients were involved in 215 trial enrollments, 110 (51.1%) of which were into a COVID treatment trial. The overall informed consent rate (proportion agreed of those eligible and approached including a priori and deferred consent models) was 83% (215/259). The informed consent rate was lower for COVID-19 trials (110/142, 77.5%) than other trials (105/117, 89.7%; p = 0.01). Patients with COVID-19 were significantly more likely to be coenrolled in two or more studies (29/77, 37.7%) compared with other patients (13/84, 15.5%; p = 0.002). Review items for each new study were collated, refined, and evolved into a modifiable checklist template to set up each study for success. The COVID Collaborative expanded to a more formal Department of Critical Care Research Operations Committee in June 2021, supporting sustainable research operations during and beyond the pandemic.

CONCLUSIONS: Structured coordination and increased communication about research operations among diverse research stakeholders cultivated a sense of shared purpose and enhanced the integrity of clinical research operations.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Cook DJ, Duan EH, Clarke FJ, et al. Multistudy Research Operations in the ICU: An Interprofessional Pandemic-Informed Approach. Crit Care Explor. 2022. PMID: 36506834. doi:10.1097/CCE.0000000000000808

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。